dc.contributor.author | Petheram, K | |
dc.contributor.author | Dobson, R | |
dc.date.accessioned | 2024-07-05T08:13:21Z | |
dc.date.available | 2024-07-05T08:13:21Z | |
dc.date.issued | 2024-06-22 | |
dc.identifier.citation | Petheram K, Dobson R. All women with multiple sclerosis should start hormone replacement therapy at menopause unless contraindicated: Commentary. Multiple Sclerosis Journal. 2024;0(0). doi:10.1177/13524585241254989 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/97859 | |
dc.format.extent | 13524585241254989 - ? | |
dc.language | eng | |
dc.publisher | SAGE Publications | en_US |
dc.relation.ispartof | Mult Scler | |
dc.rights | This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). | |
dc.title | All women with multiple sclerosis should start hormone replacement therapy at menopause unless contraindicated: Commentary. | en_US |
dc.type | Article | en_US |
dc.rights.holder | © The Author(s), 2024. | |
dc.identifier.doi | 10.1177/13524585241254989 | |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/38907631 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published online | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |